Ultraviolet radiation induced erythema is prevented or treated in a human mammal in need of such prevention or treatment, i.e., a mammal suffering from or seeking to avoid sunburn, by topically administering thereto a unit dosage erythema-preventing or treating effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.

Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.

An ibuprofen containing hydroalcoholic gel of pH 3.5 to 6.0 for topically treating inflammation or pain comprising an effective amount of ibuprofen; 40 to 60% alcohol, e.g. ethanol or isopropyl alcohol; 0-20% of a non-volatile solvent, e.g. propylene glycol; 2.0 to 5.0% gelling agents, e.g. 2.5% hydroxypropyl cellulose or 4.0% polyacrylic acid polymer; sufficient base, e.g. triethanolamine, to adjust the pH to between 3.5 and 6.0; and water; methods for delivering ibuprofen through the skin to t...

A chewable taste-masked ibuprofen tablet having controlled release characteristics.

A clear, stable, and palatable liquid ibuprofen composition has ibuprofen, or a pharmaceutically acceptable salt or ester of ibuprofen, in an aqueous medium containing a methylcellulose composition. A process of making such an ibuprofen composition is significantly simpler and less expensive to carry out than prior processes of making liquid ibuprofen compositions. The liquid ibuprofen composition may also contain pharmaceutically acceptable alcohol, dispersing and suspending agents, viscosity i...

A novel water soluble alkali metal salt of ibuprofen is prepared by reacting ibuprofen and an alkali metal bicarbonate in a aqueous medium. The salt is useful in treating pain, inflammation, and fever in mammals. It permits the preparation of a number of novel formulations which result in pharmaceutically and commercially acceptable dosage forms.

The present invention provides a sustained release .alpha.methyl-4-(2-methylpropyl)benzene acetic acid (Ibuprofen) formulation comprising sufficient granules to provide a predetermined dose or number of doses of Ibuprofen, each granule having a diameter between 0.5 and 2.0 mm and comprising: (a) a core containing 100 parts of Ibuprofen and from 10 to 70 parts of a microcrystalline cellulose; and (b) a coating covering substantially the whole surface of the core and comprising 100 parts of a wate...

S(+)-ibuprofen-L-amino acids and S(+)-ibuprofen-D-amino acids, substantially free of other ibuprofen-amino acid stereoisomers, give an onset-hastened, enhanced analgesic response in humans.

This invention relates to a self-emulsifying solution of Ibuprofen suitable for encapsulation into a soft gelatin capsule.

Pharmaceutical compositions are disclosed suitable for parenteral administration having anti-inflammatory, analgesic, and anti-pyretic properties, which consist of a therapeutically effective amount of d,l or l-lysine salt of R,S or S-ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and either substantially free or absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capa...